Literature DB >> 16328158

Pbx1 is required for Hox D3-mediated angiogenesis.

A Charboneau1, L East, N Mulholland, M Rohde, N Boudreau.   

Abstract

Our previous studies showed that the homeobox (Hox) D3 transcription factor induces expression of alphavbeta3 integrin and promotes endothelial cell (EC) migration and angiogenesis. Since binding of Hox 3 factors to target DNA is enhanced by the co-factor Pbx, we investigated whether Pbx1 is also required for angiogenesis. We observed that EC predominantly express the Pbx1b isoform. Nuclear extracts from angiogenic EC express higher levels of active Pbx1 and more effectively form complexes on Pbx1/Hox consensus DNA oligonucleotides as compared to nuclear extracts from quiescent EC. Introduction of anti-sense against Pbx1 impaired the formation of Pbx1/Hox complexes on target DNA consensus in nuclear extracts from angiogenic EC. Anti-sense against Pbx1 also impaired EC migration and blocked angiogenesis induced by bFGF in vivo. Furthermore, although the levels of Hox D3 were unchanged, expression of its target gene, beta3 integrin was reduced, consistent with impaired transcriptional activation by Hox D3. Together, these studies suggest that Pbx1 is required for pro-angiogenic Hox DNA binding and transcriptional activity in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328158     DOI: 10.1007/s10456-005-9016-7

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  20 in total

1.  Selective gene expression by rat gastric corpus epithelium.

Authors:  M Goebel; A Stengel; N W G Lambrecht; G Sachs
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

2.  Topographic patterns of vascular disease: HOX proteins as determining factors?

Authors:  Richard P Visconti; Alexander Awgulewitsch
Journal:  World J Biol Chem       Date:  2015-08-26

3.  Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5.

Authors:  Yun Chen; David H Gorski
Journal:  Blood       Date:  2007-10-23       Impact factor: 22.113

Review 4.  Role of the AP-1 transcription factor FOSL1 in endothelial cells adhesion and migration.

Authors:  Federico Galvagni; Maurizio Orlandini; Salvatore Oliviero
Journal:  Cell Adh Migr       Date:  2013-07-25       Impact factor: 3.405

Review 5.  The Hox genes and their roles in oncogenesis.

Authors:  Nilay Shah; Saraswati Sukumar
Journal:  Nat Rev Cancer       Date:  2010-04-01       Impact factor: 60.716

6.  HOXA9 methylation by PRMT5 is essential for endothelial cell expression of leukocyte adhesion molecules.

Authors:  Smarajit Bandyopadhyay; Daniel P Harris; Gregory N Adams; Gregory E Lause; Anne McHugh; Emily G Tillmaand; Angela Money; Belinda Willard; Paul L Fox; Paul E Dicorleto
Journal:  Mol Cell Biol       Date:  2012-01-23       Impact factor: 4.272

Review 7.  Vascular endothelial growth factor receptor-2 in breast cancer.

Authors:  Shanchun Guo; Laronna S Colbert; Miles Fuller; Yuanyuan Zhang; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2010-05-11

8.  The homeobox gene GAX activates p21WAF1/CIP1 expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences.

Authors:  Yun Chen; Alejandro D Leal; Sejal Patel; David H Gorski
Journal:  J Biol Chem       Date:  2006-10-30       Impact factor: 5.157

9.  Restoring transcription factor HoxA5 expression inhibits the growth of experimental hemangiomas in the brain.

Authors:  Yiqian Zhu; Ileana C Cuevas; Rodney Allanigue Gabriel; Hua Su; Stephen Nishimura; Peng Gao; Alexander Fields; Qi Hao; William L Young; Guo-Yuan Yang; Nancy J Boudreau
Journal:  J Neuropathol Exp Neurol       Date:  2009-06       Impact factor: 3.685

10.  Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.

Authors:  Atsushi Kodama; Hiroki Sakai; Satoko Matsuura; Mami Murakami; Atsuko Murai; Takashi Mori; Kouji Maruo; Tohru Kimura; Toshiaki Masegi; Tokuma Yanai
Journal:  BMC Cancer       Date:  2009-10-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.